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Abstract: Several studies have reported high prevalence of risk factors
for cardiovascular disease in adolescents.
To perform: i) systematically review the literature on the prevalence
of high blood pressure (HBP) in adolescents; ii) analyze the possible
methodological factors associated with HBP; and iii) compare the
prevalence between developed and developing countries.Beatriz Lacerda, B oreno, PhD,
áclito Barbosa Carvalho, PhD
effects. Meta-regression analysis was used to identify the sources of
heterogeneity across studies.
Fifty-five studies met the inclusion criteria and total of 122,053
adolescents included. The pooled-prevalence of HBP was 11.2%, 13%
for boys, and 9.6% for girls (P< 0.01). Method of measurement of BP
and year in which the survey was conducted were associated with
heterogeneity in the estimates of HBP among boys.
The data indicate that HBP is higher among boys than girls, and that
the method of measurement plays an important role in the overall
heterogeneity of HBP value distributions, particularly in boys.
(Medicine 93(27):e232)
Abbreviations: 95% CI = confidence interval, BPb = lood
pressure, CVD = cardiovascular diseases, HBPh = igh blood
pressure, PRISMAp = referred reporting items for systematic
reviews and meta-analyses.
INTRODUCTION
C ardiovascular diseases (CVD) are the main sources ofdisease burden worldwide, and constitute a major public
health problem in many countries.1 High blood pressure (HBP)
is an established major risk factor for stroke and coronary heart
disease.2 Studies have shown that blood pressure (BP) in child-
hood and adolescence are crucial factors in developing hyper-
tension in adulthood.3
Several studies have reported high prevalence of factors such
as abdominal obesity,4 inflammation markers,5 metabolic syn-
drome,6 and clustered metabolic risk,7 among the risk factors for
CVD. Between the cardiovascular risk factors, some article high-
lights increased BP values among adolescents as being particularly
noteworthy.8,9 Because the prevalence of obesity has been increas-
ing,4 we would expect to observe an increase in the prevalence of
HBP, since there is a strong association between obesity and
hypertension. Freedman et al10 also found that the prevalence of
obesity increased but no increase in BP was observed.
Because of these major discrepancies in the literature and
there has not been any systematic review verifying either the
prevalence of HBP among adolescents or the for identifying the
factors associated with this important aspect of adolescent health,
we systematically reviewed the literature to collate the prevalence
data of HBP among adolescents. Thus, we hypothesized the: i) the
prevalence of HBP is high in adolescents and has increased over
the past years; ii) the characteristics of the study are associated
with HBP variation; iii) and the prevalence of HBP is different
between developed and developing countries.
METHODStudies
ed the systematic review methodology
erred Reporting Items for Systematic
www.md-journal.com | 1
Reviews and Meta-Analyses (PRISMA) statement.11 This is a
systematic review article and as no data were collected on humans
or animals, therewas no need to be submitted to ethics committee.
The study is registered in the PROSPERO database
(CRD42011001422). Searches involved 10 electronic databases:
BioMed Central, Cinahl, Embase, ERIC, Medline/PubMed, Psy-
INFO, Scielo, Scopus, SportDiscus, and Web of Science. Articles
listed in the databases through August 11, 2013 were evaluated for
inclusion in the analysis. This extended number of databases was
used in order to minimize selection bias. The articles identified in
the search were reviewed and contact made with the correspond-
ing authors to solicit other relevant details, and studies that may
have been missed in our search.
An ethics statement was not required for this work and no
funding was received for this work, no funding bodies played any
role in the design, writing or decision to publish this manuscript.
Three command groups (according to key words) were
used for the database search. Within each group, we used the
Boolean operator ‘‘OR’’ and between groups we used the
Boolean operator ‘‘AND.’’ In the first group we included terms
related to BP: high blood pressure, blood pressure, and hyper-
tension. In the second group we included terms related to age:
adolescent, adolescence, young, youth, teenager, and teenage.
Given that the aim of the present review was to verify the
prevalence of HBP, in the third group we added a set of
commands to restrict study design to cross-sectional studies,
because this type of epidemiological study is the most appro-
priate for studies that attempt to estimate the prevalence. These
terms were: prevalence studies, cross-sectional studies, and
survey.
Inclusion of Studies
We included studies that published original data, in cases
of duplicated data, the studies presenting outcomes related to
our systematic review were retained and the articles that did not
meet the inclusion criteria were excluded. The duplicates were
removed using EndNote Web1 reference management soft-
ware, Thomson Reuters, Carlsbad, CA.
Potentially relevant articles were selected by: i) screening
the titles; ii) screening the abstracts; iii) and if abstracts were not
available or did not provide sufficient data, the entire article was
retrieved and screened to determine whether it met the inclusion
criteria. Abstracts were reviewed independently by 2 authors
(ACdeM and MBL) and were selected based on their consensus
according to the same criteria used described bellow. If con-
sensus was not reached, the abstract was set aside for further
evaluation. Full-text articles of abstracts selected were retrieved
and reviewed. Inclusion was based on consensus between 2
investigators (ACdeM and MBL). To be included the study the
article needed to: 1) have a representative population-based
sample that included adolescents (aged between 10 and 19 years
old; eg: if some studies had prevalence data of 10–15 yo or 15–
19 yo, they were included); 2) be a cross-sectional design
(because we are interested in verifying the prevalence of
HBP, cross-sectional studies are the kind of epidemiological
study more appropriate to check the prevalence, however we
know the limitations and were considered); 3) have employed a
probabilistic method to sample the populationa; 4) present the
HBP prevalence; 5) be an original study presenting the preva-
lence of HBP for both genders; 6) and have diagnosed HBP
de Moraes et alaccording to international guidelines: SBP and/or DBP 95th
percentile for gender, age, and height (currently just there are 2
guidelines; one of the American Academy of Pediatrics12 and
2 | www.md-journal.comother European Society of Hypertension13). We also included
those articles that did not present the prevalence per se, but
contained an estimation of prevalence by gender. Also included
were those articles that contained the confidence interval (95%
CI) according to gender. The STROBE checklist for cross-
sectional studies was applied by 2 members of the research team
in assessing the percentage of items correctly related to the
individual articles14,15 and, in case of disagreement between the
assessors, the article was evaluated by a 3rd member of the team
(see Figure 1). We not used the STROBE for to available the
quality of the studies, just check the important methodological
aspects this type of study.
Assessment, Data Extraction, and Analysis
The evaluation and data extraction were performed inde-
pendently by 2 members of the research team (ACdeM and
MBL). Disagreements were resolved by consultation within the
team until consensus was reached.
The data extracted from each study were: author, country,
publication year, year of survey, journal in which the article was
published, total study sample size, sample size of adolescents, age
of subjects in years, proportion of girls, prevalence of HBP, and risk
factors associated with HBP. The 95% CI was obtained from the
articles16–28 whenever possible, or was calculated using Stata 12.0
‘‘cii’’ command (95% CI exact for binomial distribution).29–62
The outcome of this review is the HPB prevalence’s,
diagnosed in the articles included in accordance with inter-
national guidelines. The pooled prevalence’s of HBP (total
sample and for each gender) were estimated by random effects
(estimated pooled-prevalence adjusting variation between
levels and the variation within each level). Test of heterogeneity
(Q test) was used to evaluate whether the differences in preva-
lence estimates across studies were higher than expected by
chance. Meta-regression analysis was used to identify the
sources of heterogeneity across studies by I2, initially to assess
the contribution of each variable (year of survey; geographic
location; characteristic of countries; study population; method
of BP measurement) to the overall heterogeneity.63 Those
variables that were significantly associated with the heterogen-
eity (P< 0.20) were included in a multivariate hierarchical
model.64 At the first level, year of survey (1988–1998,
1999–2004, and 2005–2009) was introduced, at the second
level were geographic location (North America, Europe, Asia,
Latin America, Oceania, Middle East, and Africa), character-
istic of countries according International Monetary Fund classi-
fication (developed or developing), and study population
(community or school); at the third level were the devices used
to measure BP (sphygmomanometer or automatic digital
monitor). This hierarchical model was constructed following
the methodology proposed by Victora et al64 where the effect of
variables increases as the level increases, approaching the out-
come, for example: the year of research theoretically has less
influence on the HBP prevalence, the geographic location, and
this has less effect that the measuring method of BP. A P value
of <0.05 was considered statistically significant in all the
analyses. The Stata 12 (Stata Corp., College Station, TX)
was used for all statistical calculations.
RESULTS
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The literature search yielded 727 titles of potentially relevant
articles (see Figure 1 for selection procedure flow diagram). Of
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Duplicates removed by Endnote
(n = 212)
















Potentially relevant titles and abstracts of
articles reviewed (n = 727)
Search for studies in databases
(n = 6995)
First screening
Articles excluded (n = 622) according to following
criteria:
1) Sample not containing adolescents (10–18 years of age):
n = 144;
2) Delineation not cross-sectional: n = 82;
3) Prevalence of HBP; only continuous values  of SBP and
DBP: n = 194;
4) Studies not showing prevalence of HBP for both  genders:
    n = 40;
5) Diagnosis of HBP not following international guidelines: n
    = 8;
6) No access to full article: n = 26;` 
7) Not a probabilistic population sample: n = 91;
8) Contains adolescents, but no indication of prevalence for
    this population: n = 37.
Potentially relevant full-text articles











(n = 55 articles) 
Second Screening
Articles excluded (n = 50) according to following
criteria:
1) Articles from which calculation of prevalence by gender
    not possible: n = 23;
2) Articles without 95%CI for both genders separately, nor





Studies included in quantitative synthesis
(n= 55 articles9, 16, 19–21, 23, 24, 29–31, 33–36, 38, 40, 
      42–44, 46–52, 54, 57-63, 66-86)
Data analysis of 67 prevalence
(n = 55articles9, 16, 19–21, 23, 24, 29–31, 33–36, 38, 40, 
    42–44, 46–52, 54, 57-63, 66-86)
FIGURE 1. Flowchart of search strategy and results. DBP¼diastolic blood pressure, HBP¼high blood pressure, SBP¼ systolic blood
pressure.
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these, 55 articles were eligible according to the inclusion criteria
established for this review.9,16,19–21,23,24,29–31,33–36,38,40,42–44,46–
52,54,56–62,65–85 The supplement file presents a description of the 55
articles with the relevant inclusion criteria including: lead author,
year of publication, country where the study was performed, year
of survey, total number of participants in the study, number of
adolescents, proportion of girls, age range, study population,
method of measurement, overall and gender-based prevalence,
and the respective 95% CI.
Among the study that used automatic digital monitors for
measuring BP, 77% used Omron BP device (Omron Healthcare
Inc., Tokyo, Japan); 22.3% did not describe which model and
0.7% used the Space Labs device.
Five articles evaluated the secular trend of prevalence, 2 of
which were from USA. The continents with the highest numbers
of studies included in this review were Asia and Latin America
(n¼ 18 in each), and only 1 study from Oceania was identified.
Of the populations studied, 55.6% were from high-school
de Moraes et alsamples; 75.5% of studies used sphygmomanometer to measure
BP; 63.5% of surveys were conducted in low- and middle-
income countries (supplementary file, http://links.lww.com/
TABLE 1. Association Between Prevalence of High Blood Pressur
























3 Method of measured BPz
Sphygmomanometer 34
Automatic digital monitor 13 1
Between-study variance assessed by moment-based e
95% CI¼ confidence interval of 95%, HBP¼ high blood pressure.
The adjusted analysis was conducted following a theoretical conceptua
survey (1988–1998, 1999–2004, and 2005–2009); 2) geographic location (N
Africa); characteristic of countries (higher or low- and middle-income); an
(sphygmomanometer or automatic digital monitor).
The effect of each variable on the outcome was adjusted for other variab
P>0.2 were not included in the subsequent adjusted models. Statistically
zEight articles are not described the method of measured blood pressure
4 | www.md-journal.comMD/A83). Total of 122,053 adolescents included in this review
(61,049 girls).
Prevalence
In the overall sample, the pooled-prevalence estimated by
random effects was of HBP was 11.2% (Table 1), 13% for boys,
and 9.6% for girls (P< 0.01). The analyses revealed significant
heterogeneity across studies for all analyses (P< 0.001): the
overall sample (Table 1), girls (Table 2) and boys (Table 3),
rejecting the hypothesis of homogeneity of results.
Table 1 summarizes the associations between HBP preva-
lence and characteristics of the study in the overall sample. In
the overall sample, the significant association of geographical
location lost significance in the adjusted model. The year of
survey was not significantly associated with the prevalence of
HBP while, conversely, the characteristic of countries and
method of measuring BP retained their significant associations.
Table 2 depicts the HBP prevalence in the girls in relation
Medicine  Volume 93, Number 27, December 2014to the methodological characteristics. Those studies from Africa
showed higher prevalence while the lowest were those studies
from Latin America. We found no significant associations
e With Methodological Covariates for Total (n¼122,053) of
Total of Sample
ooled Prevalence





























l model that had been previously formulated in three levels: 1) year of
orth America, Europe, Asia, Latin America, Oceania, Middle East, and
d study population (community or school); 3) method of measured BP
les in the same model or above in the hierarchical model. Variables with
significant associations are in bold type.
.
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1 Year of survey 0.972
1988–1998 9 9.0 (5.9–11.5) Referent
1999–2004 26 7.8 (3.4–13.8) 0.111
2005–2009 20 7 (3.1–14.1) 0.450
2 Geographic location 0.214
North America 14 5.85 (2.9–8.7) Referent
Europe 4 11.2 (7.8–15.2) 0.484
Asia 15 11.5 (6.7–18.7) 0.536
Latin America 14 4.8 (2.8–9.2) 0.913
Oceania 1 24.7 (22.7–26.8) 0.717
Middle East 4 5.0 (2.3–13.6) 0.751
Africa 3 29.0 (23.8–33.3) 0.552
Characteristic of countries 0.679
Higher income 19 7.8 (3.4–10.5) Referent
Low- and middle-income 36 9.1 (3.3–13.7) 0.755
Study population 0.746
School 26 8.6 (3.4–12.5) Referent
Community 29 7.8 (3.4–13.8) 0.995
3 Method of measured BPz 0.897
Sphygmomanometer 34 8.6 (3.7–13) Referent
Automatic digital monitor 13 10 (5.5–23.8) 0.894
Between-study variance assessed by moment-based estimate (tau2¼ 2.349)
HBP¼ high blood pressure.
The adjusted analysis was conducted following a theoretical conceptual model that had been previously formulated in three levels: 1) year of
survey (1988–1998, 1999–2004, and 2005–2009); 2) geographic location (North America, Europe, Asia, Latin America, Oceania, Middle East, and
Africa); characteristic of countries (higher or low- and middle-income); and study population (community or school); 3) method of measured BP
(sphygmomanometer or automatic digital monitor).
The effect of each variable on the outcome was adjusted for other variables in the same model or above in the hierarchical model. Variables with
P>0.2 were not included in the subsequent adjusted models. Statistically significant associations are in bold type.
sure
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characteristics.
Table 3 shows the prevalence in the boys in relation to
methodological characteristics. The highest prevalence was
observed in Oceania and the lowest in the studies conducted
in Middle East/Latin America, and North America.
Among boys, all the variables were associated with hetero-
geneity in the distributions of HBP in the univariate model, but
only the year in which the survey was conducted, the geo-
graphical location, and the method of measuring BP maintain
the significance in the adjusted model.
DISCUSSION
We conducted a comprehensive systematic review of
studies addressing the prevalence of HBP in adolescents, and
we used meta-regression to examine the possible sources of
heterogeneity in the data presented in the articles. The preva-
zEight articles are not described the method of measured blood preslence of HBP was higher among boys, and the heterogeneity
across studies was due to methodological differences, especially
method of measuring BP. Further, the prevalence of HBP was
# 2014 Lippincott Williams & Wilkinshigher among studies from low- and middle-income countries in
boys. To the best of our knowledge, this is the first systematic
review article analysing the associations between HBP preva-
lence and studies characteristic’s in adolescents, and is the most
extensive systematic review on this subject, to date.
Contrary to expectations, the prevalence of HBP was
inversely related to the year of the survey. Because the preva-
lence of obesity has been increasing4 we would expect to
observe an increase in the prevalence of HBP, since there is
a strong association between obesity and hypertension.10 Freed-
man et al10 also found that the prevalence of obesity increased
but no increase in BP was observed. The authors emphasized
that a possible explanation is the improvement of maternal and
child health86,87 and increased prevalence of breastfeeding
alone88 observed over the past 2 decades. These factors, which
are inversely associated with adolescent BP levels,89 can be
responsible for the decrease in HBP prevalence.
Boys had higher pooled prevalence than girls. There are 2
.
possible explanations for our finding: 1) studies showed that
boys has a higher accumulation of visceral fat90 and intra-
abdominal fat91 than girls, and visceral fat has been associated
www.md-journal.com | 5
















1 Year of survey <0.001
1988–1998 9 13.3 (8.7–14.6) Referent
1999–2004 26 10.3 (6.3–18.8) 0.011
2005–2009 20 9.4 (5.3–25.1) 0.004
2 Geographic location 0.004
North America 14 7.1 (3.3–10.8) Referent
Europe 4 17.5 (12.6–26.8) 0.334
Asia 15 13.9 (10.4–22.8) 0.664
Latin America 14 7.4 (4.4–13.5) 0.891
Oceania 1 24.7 (22.8–26.7) 0.607
Middle East 4 6.4 (3.4–20.0) 0.551
Africa 3 24.0 (9–46.1) 0.617
Characteristic of countries 0.003
Higher income 19 9.0 (4–18.0) Referent
Low- and middle-income 36 11.5 (6.4–22.7) 0.007
Study population 0.001
School 26 9.4 (5.1–22.8) Referent
Community 29 10.8 (6.9–16.2) 0.557
3 Method of measured BPz <0.001
Sphygmomanometer 34 9.7 (6.1–19.4) Referent
Automatic digital monitor 13 14.4 (5.1–24.7) <0.001
Between-study variance assessed by moment-based estimate (tau2 U 1.305)
HBP¼ high blood pressure.
The adjusted analysis was conducted following a theoretical conceptual model that had been previously formulated in three levels: 1) year of
survey (1988–1998, 1999–2004, and 2005–2009); 2) geographic location (North America, Europe, Asia, Latin America, Oceania, Middle East, and
Africa); characteristic of countries (higher or low- and middle-income); and study population (community or school); 3) method of measured BP
(sphygmomanometer or automatic digital monitor).
The effect of each variable on the outcome was adjusted for other variables in the same model or above in the hierarchical model. Variables with
lly
sure
de Moraes et al Medicine  Volume 93, Number 27, December 2014with higher sympathetic activity.92,93 This activation is a key
mechanism underlying the effect of intra-abdominal fat
accumulation on the development of hypertension.94 For
example, increased sympathetic flow may increase sodium
re-absorption and subsequent increased peripheral vascular
resistance resulting in increased BP.95 Also, this increased
sympathetic activation can be caused by increased testosterone
concentrations in males. Testosterone, acting as a mediator of
the androgen receptor gene function,96 has been associated not
only with increased visceral fat but also with greater vasomotor
sympathetic tone and BP in adolescent boys, compared to
girls.96 However, pubertal stage is not included in the diagnostic
criteria of HBP, and it can be a limitation, since the analysis
cannot adjust for this variable is not included in the articles
described. In our review, is not possible to analyze the influence
of the obesity on the HBP prevalence, because the cut-off points
to diagnosis the obesity in each article is different, and would
introduce a classification bias in the analyses if us carried out.
2) The girls have a higher prevalence of healthy behavior
P>0.2 were not included in the subsequent adjusted models. Statistica
zEight articles are not described the method of measured blood prespatterns (healthy eating habits97; avoidance of tobacco smok-
ing98; less alcohol abuse99; lower levels of sedentary behavior7)
than boys, and these healthy life-style choices are associated
6 | www.md-journal.comwith lower levels of BP and HBP prevalence.100–102 Addition-
ally, it was not possible to adjust the analysis for other factors
potentially associated with BP such as lifestyle, genetic factors,
intrauterine development, because theses information’s is not
provided in the articles included.
Of considerable note is that the type of device used to
measure BP was associated with heterogeneity in the prevalence
of HBP. The pooled prevalence was higher in articles using the
automatic ‘‘digital’’ monitors. However, all reported that the
monitors used had been validated for measurement of BP in
adolescents, according criteria by European Hypertension
Society and American Academy of Pediatrics for differences
between averages of the measures mercury column and tested
monitor for a device to be validated, should be 5 mmHg and
that the standard deviation of the differences of the averages is
not larger than 8 mmHg. The differences in the prevalence can
introduce differential or non-differential misclassification
effects (errors due to disease status or exposure) and may cause
underestimation or overestimation of the true prevalence.103
significant associations are in bold type.
.
Our findings suggest that automatic monitors should not be used
for diagnosis of hypertension, but may be used only as an initial
assessment of current status of cardiovascular health of the
# 2014 Lippincott Williams & Wilkins
adolescents and, should the teenager present with HBP,
additional analysis with more accurate instruments must be
performed. The logistics in epidemiological studies often pre-
clude the measurement of BP with the gold standard; for
example ambulatory BP monitoring or repeated office BP
measurements. The technique is more difficult to master and
is not cost-effective on an epidemiological scale. However,
cost-effectiveness becomes evident104 if HBP diagnosis in
adults; and the screening of the HBP in the adolescent can
lead to better and more prompt treatment and so increase life
expectancy of the adolescent, because HBP this age group
is asymptomatic.
On the other hand, recently Thompson et al105 showed that
there is no direct evidence that screening for hypertension in
children and adolescents reduces adverse cardiovascular out-
comes in adults. Are needed new research’s to improve diag-
nosis and risk stratification of children with elevated BP and to
quantify risks and benefits of interventions, because on this
review we demonstrated higher prevalence of HBP. Secondary
hypertension, although it might occasionally appear in our
results, it was not described in any article, therefore disregarded
in this review, because it is rare in the pediatric population and
interfere little in the final result of the HBP prevalence’s.
Another important factor could be influence of the classi-
fication of the HBP is the race and ethnicity, because the growth
speed is influenced by these factors,106 but the guidelines
(American Academy of Pediatrics12 and European Society of
Hypertension13) highlights that newly revised CDC growth
charts (www.cdc.gov/growthcharts) should be used for the
height percentile classification.
We observed higher HBP prevalence in low- and middle-
income countries. Previous studies conducted in these countries
reported that the hypertension was associated with low socio-
economic status.83,107 However, the nutritional burden is shift-
ing from deficiency to excess energy imbalance in these
countries, while awareness of the problem is increasing in
developed countries and, as such, the prevalence in higher
income countries is becoming stabilized, albeit not as-yet
normalized.108,109 Hence, strategies for changing lifestyles
are necessary; the objectives being to decrease the prevalence
and to increase early treatment of HBP.
CONCLUSIONS
Our systematic review indicated that HBP prevalence is
high among adolescents; higher in boys and adolescents from
low- and middle-income countries. The method of measurement
plays an important role in HBP prevalence distribution in the
overall sample, and especially in boys, but not in girls. Public
health programs that aim to reduce HBP should focus primarily
on adolescents from low- and middle-income countries.
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65. Martı́nez CA, Ibáñez JO, Paterno CA, et al. Overweight and
obesity in children and adolescents of Corrientes city. Relationship
with cardiovascular risk factors. Medicina. 2001;61:308–314.
66. Ramos E, Barros H. Prevalence of hypertension in 13-year-old
adolescents in Porto, Portugal. Rev Port Cardiol. 2005;24:1075–
1087.
67. Esmaillzadeh A, Mirmiran P, Azadbakht L, et al. High prevalence
of the metabolic syndrome in Iranian adolescents. Obesity (Silver
Spring, MD). 2006;14:377–382.
68. Jago R, Harrell JS, McMurray RG, et al. Prevalence of abnormal
lipid and blood pressure values among an ethnically diverse
population of eighth-grade adolescents and screening implications.
Pediatrics. 2006;117:2065–2073.
69. Castillo EH, Borges G, Talavera JO, et al. Body mass index and
the prevalence of metabolic syndrome among children and
adolescents in two Mexican populations. J Adolesc Health.
2007;40:521–526.
70. Singh R, Bhansali A, Sialy R, Aggarwal A. Prevalence of
metabolic syndrome in adolescents from a north Indian population.
Diabetic Med. 2007;24:195–199.
71. Pedrozo W, Rascón MC, Bonneau G, et al. Metabolic syndrome
and risk factors associated with life style among adolescents in a
city in Argentina. Pan Am J Public Health. 2008;24:149–160.
72. Seo SJ, Lee HY, Lee SW. The prevalence of the metabolic
syndrome in Korean children and adolescents: comparisons of the
criteria of Cook et al., Cruz and Goran, and Ferranti et al. Yons
Med J. 2008;49:563–572.
73. Pan Y, Pratt CA. Metabolic syndrome and its association with diet
and physical activity in US adolescents. JAMA. 2008;108:276–286.
74. Romanzini M, Reichert FF, Lopes Ada S, et al. [Prevalence of
cardiovascular risk factors in adolescents]. Cad Saude Publica.
2008;24:2573–2581.
75. Candido APC, Benedetto R, Castro APP, et al. Cardiovascular risk
factors in children and adolescents living in an urban area of
Southeast of Brazil: Ouro Preto Study. Eur J Pediatr.
2009;168:1373–1382.
Medicine  Volume 93, Number 27, December 201476. Bal C, Yalçin BM, Mazicioğlu MM, et al. Blood pressure
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